• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特人群中主要细胞色素 P450(CYP)2C9 遗传变异的分布。

Distribution of the major cytochrome P450 (CYP) 2C9 genetic variants in a Saudi population.

机构信息

King Saud Bin Abdulaziz University for Health Sciences, King Fahad Medical City, Riyadh, Saudi Arabia.

出版信息

Basic Clin Pharmacol Toxicol. 2011 Aug;109(2):111-4. doi: 10.1111/j.1742-7843.2011.00692.x. Epub 2011 Mar 28.

DOI:10.1111/j.1742-7843.2011.00692.x
PMID:21371265
Abstract

Cytochrome P450 (CYP) 2C9 is responsible for the metabolism of a number of widely used drugs such as oral anticoagulants, oral antidiabetics and non-steroidal anti-inflammatory drugs. The CYP2C9 is a genetically polymorphic enzyme. The most common allele is CYP2C91, while CYP2C92 and CYP2C9*3 are the less-frequent variants. The activity of the enzyme encoded by either CYP2C9 *2 or 3 variant is lower compared with that of the CYP2C91. The metabolism of most of the CYP2C9 substrates decreases in varying degrees in subjects carrying the CYP2C9 *2 or *3 allele. The aim of this study was to investigate the frequencies of the major variants of the CYP2C9 in Saudi Arabians.

摘要

细胞色素 P450(CYP)2C9 负责代谢许多广泛使用的药物,如口服抗凝剂、口服抗糖尿病药和非甾体抗炎药。CYP2C9 是一种遗传多态性酶。最常见的等位基因是 CYP2C91,而 CYP2C92 和 CYP2C93 是较少见的变体。由 CYP2C92 或3 变体编码的酶的活性与 CYP2C91 相比较低。携带 CYP2C92 或3 等位基因的受试者中,大多数 CYP2C9 底物的代谢程度不同程度降低。本研究旨在调查沙特阿拉伯人中 CYP2C9 的主要变体的频率。

相似文献

1
Distribution of the major cytochrome P450 (CYP) 2C9 genetic variants in a Saudi population.沙特人群中主要细胞色素 P450(CYP)2C9 遗传变异的分布。
Basic Clin Pharmacol Toxicol. 2011 Aug;109(2):111-4. doi: 10.1111/j.1742-7843.2011.00692.x. Epub 2011 Mar 28.
2
Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.细胞色素P450 2C8(CYP2C8)与细胞色素P450 2C9(CYP2C9)基因多态性之间的连锁关系
Biochem Biophys Res Commun. 2002 Nov 22;299(1):25-8. doi: 10.1016/s0006-291x(02)02592-5.
3
Association between the CYP2C9 polymorphism and the drug metabolism phenotype.细胞色素P450 2C9基因多态性与药物代谢表型之间的关联。
Clin Chem Lab Med. 2004 Jan;42(1):72-8. doi: 10.1515/CCLM.2004.014.
4
Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants.细胞色素P450 2C9的等位基因变体可改变非甾体抗炎药与香豆素抗凝剂之间的相互作用。
Clin Pharmacol Ther. 2005 Jun;77(6):479-85. doi: 10.1016/j.clpt.2005.02.009.
5
Clinical drugs undergoing polymorphic metabolism by human cytochrome P450 2C9 and the implication in drug development.临床药物经人细胞色素 P450 2C9 多态代谢及其在药物开发中的意义。
Curr Med Chem. 2011;18(5):667-713. doi: 10.2174/092986711794480131.
6
Frequency of cytochrome P450 2C9 allelic variants in the Chinese and French populations.中国和法国人群中细胞色素P450 2C9等位基因变体的频率。
Fundam Clin Pharmacol. 2003 Jun;17(3):373-6. doi: 10.1046/j.1472-8206.2003.00148.x.
7
Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population.伊朗健康人群中细胞色素P450酶2C9和2C19的基因多态性
Clin Exp Pharmacol Physiol. 2007 Jan-Feb;34(1-2):102-5. doi: 10.1111/j.1440-1681.2007.04538.x.
8
Catalytic activities of human cytochrome P450 2C9*1, 2C9*3 and 2C9*13.人细胞色素P450 2C9*1、2C9*3和2C9*13的催化活性。
Xenobiotica. 2005 Sep;35(9):853-61. doi: 10.1080/00498250500256367.
9
Allele and genotype frequencies of CYP2C9 within an Iranian population (Mazandaran).伊朗人群(马赞德兰省)中CYP2C9的等位基因和基因型频率。
Genet Test Mol Biomarkers. 2012 Jul;16(7):817-21. doi: 10.1089/gtmb.2011.0301. Epub 2012 Jan 30.
10
Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.细胞色素P450(CYP)2C9和CYP2C8基因多态性对口服抗糖尿病药物药代动力学的影响:临床相关性
Clin Pharmacokinet. 2005;44(12):1209-25. doi: 10.2165/00003088-200544120-00002.

引用本文的文献

1
The impact of , , and polymorphisms on warfarin dose requirement in Saudi patients.[基因名称1]、[基因名称2]和[基因名称3]多态性对沙特患者华法林剂量需求的影响。
Front Pharmacol. 2025 Apr 30;16:1547142. doi: 10.3389/fphar.2025.1547142. eCollection 2025.
2
Exploring the Pharmacokinetics of Drugs in Disabled Saudi Patients: A Systematic Review.探索沙特残疾患者药物的药代动力学:一项系统评价。
Pharmaceuticals (Basel). 2025 Apr 16;18(4):582. doi: 10.3390/ph18040582.
3
Frequencies of CYP2C9 polymorphisms in a Syrian cohort.叙利亚人群中CYP2C9基因多态性的频率。
BMC Genomics. 2025 Feb 13;26(1):140. doi: 10.1186/s12864-025-11310-9.
4
Genetic variation of CYP2C9 gene and its correlation with cardiovascular disease risk factors.CYP2C9 基因的遗传变异及其与心血管疾病危险因素的相关性。
Mol Biol Rep. 2024 Jan 16;51(1):105. doi: 10.1007/s11033-023-09151-4.
5
Genetic Polymorphism of CYP2C9 Among Sistani Ethnic Group in Gorgan.戈尔甘锡斯坦族群中CYP2C9的基因多态性
Indian J Clin Biochem. 2018 Apr;33(2):208-213. doi: 10.1007/s12291-017-0660-7. Epub 2017 May 26.
6
Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region.遗传多态性对中东和北非地区苯妥英药代动力学和临床结局的影响。
Drugs R D. 2017 Sep;17(3):341-361. doi: 10.1007/s40268-017-0195-7.
7
Cytochrome P450 2C9 (CYP2C9) polymorphisms in Chinese Li population.中国黎族人群细胞色素P450 2C9(CYP2C9)基因多态性
Int J Clin Exp Med. 2015 Nov 15;8(11):21024-33. eCollection 2015.
8
Individualized medicine enabled by genomics in Saudi Arabia.沙特阿拉伯基因组学助力的个性化医疗。
BMC Med Genomics. 2015;8 Suppl 1(Suppl 1):S3. doi: 10.1186/1755-8794-8-S1-S3. Epub 2015 Jan 15.
9
Genotyping of CYP2C9 and VKORC1 in the Arabic population of Al-Ahsa, Saudi Arabia.沙特阿拉伯阿哈萨阿拉伯人群 CYP2C9 和 VKORC1 的基因分型。
Biomed Res Int. 2013;2013:315980. doi: 10.1155/2013/315980. Epub 2013 Mar 17.
10
Genotype-phenotype correlation of cytochrome P450 2C9 polymorphism in Indian National Capital Region.印度国家首都地区细胞色素P450 2C9基因多态性的基因型-表型相关性
Eur J Drug Metab Pharmacokinet. 2013 Dec;38(4):275-82. doi: 10.1007/s13318-013-0124-2. Epub 2013 Feb 28.